NCT01957579 A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies Status COMPLETED Phase PHASE1
NCT01955681 A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World. Status COMPLETED Phase N/A
NCT01955668 AZD6738 First Time in Patient Multiple Ascending Dose Study Status COMPLETED Phase PHASE1
NCT01952392 Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome Status COMPLETED Phase N/A
NCT01951599 To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food. Status COMPLETED Phase PHASE1
NCT01947946 Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma Status TERMINATED Phase PHASE3
NCT01947868 Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor Status COMPLETED Phase N/A
NCT01944618 forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP) Status TERMINATED Phase N/A
NCT01942135 Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) Status COMPLETED Phase PHASE3
NCT01941849 Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma Status WITHDRAWN Phase PHASE1
NCT01940770 Specific Clinical Experience Investigation for Long-term Use of Bydureon. Status COMPLETED Phase N/A
NCT01938612 A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT01937338 Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge Status COMPLETED Phase PHASE1
NCT01936376 A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers Status UNKNOWN Phase N/A
NCT01934335 Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer Status TERMINATED Phase PHASE2
NCT01933932 Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01931761 Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers Status COMPLETED Phase PHASE1